Nova Patents
PL354891A1

Methods and compositions utilizing quinazolinones

Abstract

Quinazolinones of formulae (1a), (1b), (1c) and (1d) are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.

Term

Term ended

Projected expiry passed 26 October 2020, 5.9 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

101 members in 24 offices

This recordMember, by publication datePriority claim14 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
19825399United States of AmericaP
19825399United States of AmericaP
21310400United States of AmericaP
21310400United States of AmericaP
0060213104–––
9960198253–––
US19990198253P–––
US20000213104P–––

Members101

Family members, oldest first
DocumentOfficeKind
CA2388646A1CanadaA1
WO0130768A1World Intellectual Property Organization (WIPO)A1
AU1439801AAustraliaA
CA2413426A1CanadaA1
WO0198278A1World Intellectual Property Organization (WIPO)A1
AU5927001AAustraliaA
NO20021907D0NorwayD0
NO20021907LNorwayL
BR0015110ABrazilA
EP1226129A1European Patent Office (EPO)A1
KR20020062930ARepublic of KoreaA
WO0130768A9World Intellectual Property Organization (WIPO)A9
ZA200202930BSouth AfricaB
IL149164D0IsraelD0
CZ20021428A3CzechiaA3
HK1045994A1Hong Kong, ChinaA1
NO20026172D0NorwayD0
NO20026172LNorwayL
JP2003048881AJapanA
EP1296959A1European Patent Office (EPO)A1
JP2003512461AJapanA
US6545004B1United States of AmericaB1
CN1413198AChinaA
BR0111898ABrazilA
US6562831B1United States of AmericaB1
CZ20024178A3CzechiaA3
HU0203430A2HungaryA2
ZA200210133BSouth AfricaB
KR20030047903ARepublic of KoreaA
IL153554D0IsraelD0
HU0203430A3HungaryA3
CN1437585AChinaA
MXPA02004162AMexicoA
MXPA02012627AMexicoA
US6630479B1United States of AmericaB1
HK1053837A1Hong Kong, ChinaA1
HU0301201A2HungaryA2
JP2004501140AJapanA
US2004023996A1United States of AmericaA1
NZ518480ANew ZealandA
PL354891A1This recordPolandA1
HU0301201A3HungaryA3
AU774748B2AustraliaB2
PL358412A1PolandA1
AU2004218601A1AustraliaA1
NZ523233ANew ZealandA
US6831085B1United States of AmericaB1
US2004254203A1United States of AmericaA1
NZ530074ANew ZealandA
KR20050049562ARepublic of KoreaA
US2005187232A1United States of AmericaA1
CN1229353CChinaC
EP1296959B1European Patent Office (EPO)B1
AT323684TAustriaT
DE60118921D1GermanyD1
EP1226129B1European Patent Office (EPO)B1
AT327224TAustriaT
DE60028227D1GermanyD1
DK1296959T3DenmarkT3
PT1296959EPortugalE
EP1686120A2European Patent Office (EPO)A2
AU2001259270B2AustraliaB2
CN1824656AChinaA
US7105668B1United States of AmericaB1
EP1707563A2European Patent Office (EPO)A2
DE60118921T2GermanyT2
ES2262649T3SpainT3
AU2006236024A1AustraliaA1
NO322825B1NorwayB1
ES2263501T3SpainT3
SI1296959T1SloveniaT1
DE60028227T2GermanyT2
IL149164AIsraelA
EP1686120A3European Patent Office (EPO)A3
EP1707563A3European Patent Office (EPO)A3
US7230000B1United States of AmericaB1
NO324440B1NorwayB1
US2007254902A1United States of AmericaA1
US7294634B2United States of AmericaB2
CN100381428CChinaC
JP4116332B2JapanB2
KR100847788B1Republic of KoreaB1
US2008182864A1United States of AmericaA1
CN101302204AChinaA
CA2388646CCanadaC
IL153554AIsraelA
US7589098B2United States of AmericaB2
PL203998B1PolandB1
PL204525B1PolandB1
US7671200B2United States of AmericaB2
US2010063073A1United States of AmericaA1
US7763628B2United States of AmericaB2
US2010210670A1United States of AmericaA1
CA2413426CCanadaC
US8008311B2United States of AmericaB2
JP4854906B2JapanB2
CZ303007B6CzechiaB6
US2013053408A1United States of AmericaA1
US8470838B2United States of AmericaB2
HU229078B1HungaryB1
Showing 100 of 101